Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
19-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
19-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #38694
advertisement
Myers JS
18
Showing records 1 to 18 |
Display all abstracts from
Myers JS
77131
Contemporary approach to the diagnosis and management of primary angle-closure disease
Razeghinejad MR
Survey of Ophthalmology
2018; 63: 754-768
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Cui QN
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Myers JS
Advances in Therapy
2018; 35: 395-407
77131
Contemporary approach to the diagnosis and management of primary angle-closure disease
Myers JS
Survey of Ophthalmology
2018; 63: 754-768
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Fudemberg SJ
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Masood I
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Resende AF
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Hornbeak DM
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Vu TA
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Belda JI; Auffarth G
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Zhou C; Rahmatnejad K
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Jünemann A
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Hark LA
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Giamporcaro JE
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Myers JS
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Martínez-de-la-Casa JM; Ahmed IIK
Advances in Therapy
2018; 35: 395-407
76422
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography
Katz LJ; Waisbourd M
International Ophthalmology
2019; 39: 533-540
76564
Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Voskanyan L; Katz LJ
Advances in Therapy
2018; 35: 395-407
Issue
19-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept